2019
DOI: 10.1016/j.compbiolchem.2019.107136
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacoinformatics-based identification of anti-bacterial catalase-peroxidase enzyme inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 53 publications
(70 reference statements)
0
13
0
Order By: Relevance
“…The RMSD, docking score, Glide score, and binding energy were recorded for each molecule (Kerzare et al, 2016). The Virtual Screening Workflow (VSW) available on the Schrodinger suite is a grid-based ligand docking with energetics module (Friedrich et al, 2017;Jangam et al, 2019). The VSW was used for the rigorous screening, docking, and validation studies of the natural product dataset.…”
Section: Molecular Docking and Virtual Screening Workflowmentioning
confidence: 99%
“…The RMSD, docking score, Glide score, and binding energy were recorded for each molecule (Kerzare et al, 2016). The Virtual Screening Workflow (VSW) available on the Schrodinger suite is a grid-based ligand docking with energetics module (Friedrich et al, 2017;Jangam et al, 2019). The VSW was used for the rigorous screening, docking, and validation studies of the natural product dataset.…”
Section: Molecular Docking and Virtual Screening Workflowmentioning
confidence: 99%
“…As such, developing small molecules or other chemotherapeutic strategies to inhibit these enzymes may be a viable option to defend against these bacterial infections. The identification of these bacterium-specific inhibitors is being researched currently and includes small molecules that inhibit M. tuberculosis catalase ( 78 ). A plausible future direction of our work may include screening preexisting banks of small molecules against purified GBS NADH peroxidase protein or creating a crystal structure to identify regions for targeted drug design.…”
Section: Discussionmentioning
confidence: 99%
“…As such, developing small molecules or other chemotherapeutic strategies to inhibit these enzymes may be viable option to defend against these bacterial infections. Identification of these bacteria-specific inhibitors are being researched currently and include small molecules which inhibit M. tuberculosis catalase (84). A plausible future direction of our work may include screening pre-existing banks of small molecules against purified GBS NADH peroxidase protein or creating a crystal structure to identify regions for targeted drug design.…”
Section: Discussionmentioning
confidence: 99%